Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in April 2019.
Conference details:William Blair 3rd Annual Late-Stage Therapeutics ConferenceDate: Thursday, April 4, 2019Location: New York, New York Jefferies 6th Annual IO Cell Therapy SummitDate: Friday, April 5, 2019Presentation Time: 3:45 p.m. EDT Location: Boston, Massachusetts HC Wainwright Global Life Sciences ConferenceDate:Monday, April 8, 2019Presentation Time: 10:10 a.m. CESTLocation:London, United KingdomWebcast: Celyad’s website, under Events & Webcasts section Kempen Life Science ConferenceDate:Tuesday, April 16, 2019Presentation Time: 2.55 p.m. CESTLocation:Amsterdam, Netherlands
